Manav Wadhawan, Subash Gupta, Neerav Goyal, Sunil Taneja, Ajay Kumar – 21 June 2013 – Hepatitis B immune globulin (HBIG) is routinely used in liver transplantation for hepatitis B virus (HBV)–related liver disease. With potent oral antivirals, HBIG may not be required. We conducted a prospective trial to evaluate living related liver transplantation (LRLT) without HBIG. Eighty‐nine patients with HBV‐related liver disease underwent LRLT between January 2005 and January 2012. All donors were vaccinated with the HBV vaccine.

Javier Fernandez, Vicente Arroyo – 21 June 2013 – Watch a video presentation of this article

Richard Moreau, Vicente Arroyo – 21 June 2013 – Watch a video presentation of this article

Shih‐Wei Lai, Kuan‐Fu Liao – 21 June 2013 – Watch a video presentation of this article

Javier Fernandez, Vicente Arroyo – 21 June 2013 – Watch a video presentation of this article

Brett E. Fortune, Guadalupe Garcia‐Tsao – 21 June 2013 – Watch a video presentation of this article

Richard Moreau, Vicente Arroyo – 21 June 2013 – Watch a video presentation of this article

Sang Hyun Lee, Mi Sook Gwak, Soo Joo Choi, Hui Gyeong Park, Gaab Soo Kim, Myung Hee Kim, Hyun Joo Ahn, Jieae Kim, Choon Hyuck Kwon, Tae Seok Kim – 21 June 2013 – Postoperative analgesia and care for living liver donors have become particular interests for clinicians as the use of living donor liver transplantation has increased. Local anesthetic–based analgesia has been known to provide effective pain control.

Mauro Bernardi – 21 June 2013 – Watch a video presentation of this article

Mauro Bernardi – 21 June 2013 – Watch a video presentation of this article